Skip to content
Novocol Pharma Logo Novocol Pharma Logo Novocol Pharma Logo
  • ABOUT
    • WHO WE ARE
    • GOVERNANCE
      • CODE OF ETHICS
      • FORCED LABOUR REPORT
      • CSR ENGAGEMENT REPORT
      • ACCESSIBILITY
  • MANUFACTURING
    • FILL-FINISH
    • COMBINATION DRUG PRODUCT ASSEMBLY
  • DEVELOPMENT
    • DRUG DEVELOPMENT & ANALYTICAL SERVICES
    • DRUG DELIVERY DESIGN
  • QUALITY & COMPLIANCE
  • NEWS & EVENTS
  • CAREERS
  • CONTACT

COVID – 19 Update

Home/news/COVID – 19 Update
COVID – 19 Update
  • View Larger Image COVIF-19 Stock image


Novocol Pharma is actively supporting the prevention of COVID-19 transmission in Canada.

Measures have been implemented to protect our employees and our community. We are adopting federal and provincial government advisories and recommended practices, as they are released.

Although we are unable to receive visitors or conduct business travel at the present time, we remain fully operational and continue to deliver products and services to our valued customers and patients.

ericlee2020-04-28T14:14:26+00:00

Recent Posts

  • Novocol Pharma, a Septodont Company, Marks Project Vista Completion with Ribbon Cutting Event
  • MODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES
  • Atif Zia, President of Novocol, interviewed by Pharma’s Almanac
  • CPHI Worldwide
  • BIO Digital Event

Recent Comments

    Archives

    • October 2024
    • May 2023
    • February 2023
    • September 2022
    • May 2021
    • April 2021
    • March 2021
    • September 2020
    • June 2020
    • April 2020
    • March 2020
    • February 2020
    • November 2019

    Categories

    • events
    • news
    • Uncategorized
    Novocol Pharma © Copyright | All Rights Reserved.